Form 4 for SNOW Snowflake Inc.
Accepted 2026-07-01 19:33:01 ET · period of report 2026-06-29 · accession 0001402348-26-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-01 19:33 | 2026-06-29 | SNOW | Slootman Frank | Dir | M - OptEx | $8.88 | +99.9K | 128.4K | +350% | +$887.1K |
| DMT | 2026-07-01 19:33 | 2026-06-29 | SNOW | Slootman Frank | Dir | S - Sale+OE | $251.73 | -99.9K | 28.5K | -78% | -$25.15M |
| DT | 2026-07-01 19:33 | 2026-06-29 | SNOW | Slootman Frank | Dir | M - OptEx | $0.00 | -99.9K | 5.04M | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-29 | M | A | 99,900 | $8.88 | 128,435 | D | — | — | (F1) The exercise and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 2 | Common | Common Stock | 2026-06-29 | S | D | 24,680 | $250.46 | 103,755 | D | — | — | (F1) The exercise and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F3) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $250.000 to $250.990, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 3 | Common | Common Stock | 2026-06-29 | S | D | 39,663 | $251.55 | 64,092 | D | — | — | (F1) The exercise and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F4) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $251.000 to $251.995, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 4 | Common | Common Stock | 2026-06-29 | S | D | 19,988 | $252.35 | 44,104 | D | — | — | (F1) The exercise and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F5) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $252.000 to $252.980, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 5 | Common | Common Stock | 2026-06-29 | S | D | 15,411 | $253.39 | 28,693 | D | — | — | (F1) The exercise and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F6) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $253.010 to $253.970 inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 6 | Common | Common Stock | 2026-06-29 | S | D | 158 | $254.20 | 28,535 | D | — | — | (F1) The exercise and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F7) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $254.170 to $254.220, inclusive. (F2) Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-06-29 | M | D | 99,900 | $0.00 | 5,036,655 | D | $8.88 · — to 2029-05-28 | 99,900 Common Stock | (F1) The exercise and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. (F12) The stock option is fully vested. |